| Product Code: ETC6736679 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Artificial Blood Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Artificial Blood Market Revenues & Volume, 2021 & 2031F |
3.3 China Artificial Blood Market - Industry Life Cycle |
3.4 China Artificial Blood Market - Porter's Five Forces |
3.5 China Artificial Blood Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 China Artificial Blood Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
3.7 China Artificial Blood Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
3.8 China Artificial Blood Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 China Artificial Blood Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases that require blood transfusions |
4.2.2 Technological advancements in artificial blood products |
4.2.3 Rising healthcare expenditure in China |
4.3 Market Restraints |
4.3.1 Regulatory challenges in approval and adoption of artificial blood products |
4.3.2 Ethical concerns surrounding the use of artificial blood |
4.3.3 High manufacturing costs of artificial blood products |
5 China Artificial Blood Market Trends |
6 China Artificial Blood Market, By Types |
6.1 China Artificial Blood Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Artificial Blood Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 China Artificial Blood Market Revenues & Volume, By Anemia, 2021- 2031F |
6.1.4 China Artificial Blood Market Revenues & Volume, By Organ transplant, 2021- 2031F |
6.1.5 China Artificial Blood Market Revenues & Volume, By Injuries, 2021- 2031F |
6.1.6 China Artificial Blood Market Revenues & Volume, By Cardiovascular diseases, 2021- 2031F |
6.1.7 China Artificial Blood Market Revenues & Volume, By Maternal conditions, 2021- 2031F |
6.1.8 China Artificial Blood Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Artificial Blood Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 China Artificial Blood Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 China Artificial Blood Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 China Artificial Blood Market Revenues & Volume, By Blood banks, 2021- 2031F |
6.3 China Artificial Blood Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 China Artificial Blood Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Artificial Blood Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 China Artificial Blood Market Revenues & Volume, By Blood banks, 2021- 2031F |
6.4 China Artificial Blood Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 China Artificial Blood Market Revenues & Volume, By Hemoglobin-based oxygen carriers, 2021- 2031F |
6.4.3 China Artificial Blood Market Revenues & Volume, By Perfluorocarbon emulsion, 2021- 2031F |
7 China Artificial Blood Market Import-Export Trade Statistics |
7.1 China Artificial Blood Market Export to Major Countries |
7.2 China Artificial Blood Market Imports from Major Countries |
8 China Artificial Blood Market Key Performance Indicators |
8.1 Research and development investments in artificial blood technologies |
8.2 Number of clinical trials and studies conducted on artificial blood products |
8.3 Adoption rate of artificial blood products in hospitals and healthcare facilities. |
9 China Artificial Blood Market - Opportunity Assessment |
9.1 China Artificial Blood Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Artificial Blood Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
9.3 China Artificial Blood Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
9.4 China Artificial Blood Market Opportunity Assessment, By Product, 2021 & 2031F |
10 China Artificial Blood Market - Competitive Landscape |
10.1 China Artificial Blood Market Revenue Share, By Companies, 2024 |
10.2 China Artificial Blood Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here